Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Hypercalcemia of Malignancy|Metastatic Cancer|Pain
Interventions: BIOLOGICAL: monoclonal antibody CAL|DRUG: zoledronic acid
Sponsor: Chugai Pharmaceutical
Collaborators: National Cancer Institute (NCI)